Equity
Total Equity
ResMed Total Equity increased by 2.7% to $6.49B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.1%, from $5.55B to $6.49B. Over 4 years (FY 2021 to FY 2025), Total Equity shows an upward trend with a 19.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryMarket Position
SignalHigher is better
VolatilityStable
First reportedQ3 2013
Last reportedQ4 2025
How to read this metric
A growing equity base suggests increasing value for shareholders, though aggressive share buybacks can intentionally reduce this figure.
Detailed definition
The residual interest in the assets of the company after deducting all liabilities. It represents the net book value of...
Peer comparison
Used to calculate Return on Equity (ROE), a primary measure of how effectively management is using shareholder capital to generate profit.
Metric ID:
total_stockholders_equityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.89B | $3.03B | $3.15B | $3.28B | $3.36B | $3.43B | $3.74B | $3.93B | $4.13B | $4.25B | $4.48B | $4.63B | $4.86B | $5.20B | $5.25B | $5.55B | $5.97B | $6.12B | $6.32B | $6.49B |
| QoQ Change | — | +4.9% | +4.0% | +4.2% | +2.5% | +2.1% | +8.9% | +5.2% | +5.0% | +2.9% | +5.4% | +3.3% | +5.1% | +6.8% | +1.1% | +5.6% | +7.6% | +2.6% | +3.3% | +2.7% |
| YoY Change | — | — | — | — | +16.5% | +13.4% | +18.8% | +19.9% | +22.9% | +23.8% | +19.9% | +17.7% | +17.8% | +22.2% | +17.2% | +19.8% | +22.7% | +17.8% | +20.3% | +17.1% |
Range$2.89B – $6.49B
CAGR+18.6%
Avg YoY Growth+19.2%
Median YoY Growth+19.3%
Current Streak19+ quarters growth
Total Equity at Other Companies
Frequently Asked Questions
- What is ResMed's total equity?
- ResMed (RMD) reported total equity of $6.49B in Q1 2026.
- How has ResMed's total equity changed year-over-year?
- ResMed's total equity increased by 17.1% year-over-year, from $5.55B to $6.49B.
- What is the long-term trend for ResMed's total equity?
- Over 4 years (2021 to 2025), ResMed's total equity has grown at a 19.9% compound annual growth rate (CAGR), from $2.89B to $5.97B.
- What does total equity mean?
- The net worth of the company belonging to the owners, calculated as total assets minus total liabilities.